Omeros expects YARTEMLEA to drive company-wide positive cash flow within 18 months as early TA-TMA uptake builds (NASDAQ:OMER)

Omeros (OMER) Q1 2026 earnings call recap: YARTEMLEA launch revenue, uptake, J-code/NTAP catalysts, cash outlook & EMA timing.